Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors	ATM Gene Mutation; BRCA Mutation; BRCA1 Mutation; BRCA2 Mutation; Checkpoint Kinase 2 Gene Mutation; PALB2 Gene Mutation	Active, not recruiting	Phase 1	2026-09-15		NCT06177171

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
Varun Monga, MBBS	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Francisco	San Francisco	United States	294

Clinical trials